Navigation Links
Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
Date:2/10/2009

assessment panel that was blinded to the treatment assignments.

The most common serious toxicities (>5%) seen in previous trials of pixantrone include grade 3 and 4 neutropenia and febrile neutropenia. Complete safety information is not yet available for the study, however, the study was monitored on an ongoing basis by an independent Data Safety Monitoring Committee and no serious concerns were raised.

The study received Special Protocol Assessment approval from the U.S. Food and Drug Administration (FDA) in 2004 and pixantrone has received fast track designation for this indication.

About Pixantrone

Pixantrone (BBR 2778), a DNA intercalating antitumor agent that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown to be very active clinically in a number of tumor types, such as lymphoma, leukemia, and breast cancer. For these diseases, anthracycline-containing chemotherapy regimens are effective in first-line (initial) treatment. However, they may cause cumulative heart damage that limits lifetime dosage and does not allow for retreatment. Pixantrone has been designed to reduce the potential for heart damage compared to currently available anthracyclines or anthracenediones without a loss in anti-tumor or immunomodulatory activities.

About IDIS

IDIS is the world leader in the development and implementation of named patient programs and has a proven track record of working in strategic partnership with US-based companies to bring new drugs to Europe for the first time. IDIS supports customers in over 100 countries, supplying more than 400 different medicines per m
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
2. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
5. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
6. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
7. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
8. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
11. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 MiMedx Group, Inc. (NASDAQ: ... and marketer of patent protected regenerative biomaterials and ... that it has entered into a distribution agreement ... provide its dehydrated human amnion/chorion membrane ("dHACM") allograft ... on a private label basis. The ...
(Date:9/18/2014)... ANN ARBOR, Mich. , Sept. 18, 2014 /PRNewswire-USNewswire/ ... Medical Research will allow the University of Michigan to ... The Glenn Center for Aging Research ... growing evidence that drugs can slow the effects of ... to unlock mechanisms of aging that can help develop ...
(Date:9/18/2014)... announces the list of stocks featured in the Analyst ... the latest news and events impacting stocks and the ... Avanir Pharmaceuticals (Nasdaq: AVNR - Free Report ), ... Orexigen (Nasdaq: OREX - Free Report ), Medivation ... (Nasdaq: GILD - Free Report ). ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... ANGELES, Sept. 29, 2011 A west coast secret is ... All the way from Beverly Hills, California, a health and ... headlines ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is ... shown in less than 4 weeks of use.  Just a ...
... Awarepoint Corporation , the leading provider ... announced today that it received Frost & Sullivan,s ... Strategy Leadership Award .  The award recognizes ... and workflow automation solutions that significantly differentiates Awarepoint ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 3
(Date:9/18/2014)... Relias Learning, the leader in SaaS-based training and ... announced it has been named to the Inc. 5000 list ... , In the three-year period from 2010 to 2013, Relias ... on the Inc. 5000 list to 1,025 from the company’s ... we serve continue to grow, and the need for quality ...
(Date:9/18/2014)... PlatinumCode, a leading manufacturer and ... for the healthcare industry, announced earlier this month ... of their profits of the sale of eligible ... the announcement, PlatinumCode has launched various marketing efforts ... and hospital labs with their popular “Pink Packs” ...
(Date:9/18/2014)... “Awesome” is the way Emily W. describes ... Today) Internship Program at ARDX ( http://www.ardx.net ). ... program as “Inspirational” and “Life-changing,” respectively. None of ... would be doing during their summer internship. Stacie ... other mindless tasks,” but, instead she was doing real, ...
(Date:9/18/2014)... HealthDay Reporter WEDNESDAY, Sept. ... number of post-traumatic stress disorder symptoms are almost three times ... study suggests. The findings don,t prove a direct ... food. And it,s also possible that certain women are prone ... Still, the research seems to add to existing evidence ...
(Date:9/18/2014)... Fit Body Boot Camp , an internationally ... the country and its popularity, as both a franchise and ... in 2014. , The company’s annual business conference, the ... Costa Mesa, CA on September 26 and 27, and is ... Bedros Keuilian, who is also considered the leading fitness marketing ...
Breaking Medicine News(10 mins):Health News:Relias Learning Named to Inc. 5000 List for Second Consecutive Year 2Health News:PlatinumCode Commits to Donating Five Percent of Profits from the sale of Pink Products to Support Breast Cancer Awareness 2Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3
... MONDAY, Oct. 31 (HealthDay News) --,The longer they live in ... immigrants will develop health problems, a new study says. ... Nutrition Examination Survey and discovered a dramatic increase in obesity, ... in the United States for more than 20 years. ...
... developed a new way to assess a common cause ... Disease Activity Index. A study describing the index was ... Annual Scientific Meeting and Postgraduate Course in Washington. The ... severity. "Until now, physicians have not ...
... on nutrients carried to them by the blood stream. ... hallmark of cancer, and studies have shown that preventing ... To better understand the relationship between cancer and the ... of the complete network of blood vessels in organs. ...
... Tech-savvy teens with acne used their medicine more frequently ... a new study from Wake Forest Baptist Medical Center ... test whether a weekly Internet-based communication could improve teenagers, ... "Dermatologists have a number of effective topical agents for ...
... Surgeons at UK HealthCare recently became the first ever to ... transplantation. Wanda Craig, of Lexington, Ky., is the first patient ... of 68, she is also the oldest living human to ... known as an extracorporeal membrane oxygenation (ECMO). For more ...
... could help GPs to speed up the diagnosis and ... common forms of cancer, potentially saving thousands of lives ... and ClinRisk Ltd have shown that the algorithm is ... lung cancer at an earlier stage by ,red-flagging, potentially ...
Cached Medicine News:Health News:Life in U.S. Not Always a Plus for Immigrants' Health 2Health News:The power of the Internet: It helps improve teens' acne 2Health News:UK HealthCare surgeons are first to perform novel procedures prior to transplant 2Health News:UK HealthCare surgeons are first to perform novel procedures prior to transplant 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 2Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: